TRex Bio Inc. (NASDAQ: TRXB) Stock Competitors & Peer Comparison

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, RPRX has a market cap of 29.6B. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while RPRX trades at $66.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas RPRX's P/E ratio is 12.67. In terms of profitability, TRXB's ROE is N/A, compared to RPRX's ROE of +0.12%. Regarding short-term risk, TRXB is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check RPRX's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while WBA trades at $11.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas WBA's P/E ratio is -1.64. In terms of profitability, TRXB's ROE is N/A, compared to WBA's ROE of -0.57%. Regarding short-term risk, TRXB is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check WBA's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, CORT has a market cap of 8.7B. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while CORT trades at $80.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas CORT's P/E ratio is 229.89. In terms of profitability, TRXB's ROE is N/A, compared to CORT's ROE of +0.08%. Regarding short-term risk, TRXB is more volatile compared to CORT. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check CORT's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, KNSA has a market cap of 7.1B. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while KNSA trades at $90.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas KNSA's P/E ratio is 69.77. In terms of profitability, TRXB's ROE is N/A, compared to KNSA's ROE of +0.17%. Regarding short-term risk, TRXB is more volatile compared to KNSA. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check KNSA's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, LQDA has a market cap of 3.7B. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while LQDA trades at $41.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas LQDA's P/E ratio is 30.55. In terms of profitability, TRXB's ROE is N/A, compared to LQDA's ROE of +1.50%. Regarding short-term risk, TRXB is less volatile compared to LQDA. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check LQDA's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, PBH has a market cap of 2.4B. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while PBH trades at $49.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas PBH's P/E ratio is 11.26. In terms of profitability, TRXB's ROE is N/A, compared to PBH's ROE of +0.09%. Regarding short-term risk, TRXB is more volatile compared to PBH. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check PBH's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while HROWL trades at $25.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas HROWL's P/E ratio is N/A. In terms of profitability, TRXB's ROE is N/A, compared to HROWL's ROE of -1.04%. Regarding short-term risk, TRXB is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check HROWL's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while HROWM trades at $26.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas HROWM's P/E ratio is N/A. In terms of profitability, TRXB's ROE is N/A, compared to HROWM's ROE of -1.04%. Regarding short-term risk, TRXB is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check HROWM's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, LTGO has a market cap of 811.5M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while LTGO trades at $13.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas LTGO's P/E ratio is -5.35. In terms of profitability, TRXB's ROE is N/A, compared to LTGO's ROE of N/A. Regarding short-term risk, TRXB is less volatile compared to LTGO. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check LTGO's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, HELP has a market cap of 545.5M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while HELP trades at $8.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas HELP's P/E ratio is -2.11. In terms of profitability, TRXB's ROE is N/A, compared to HELP's ROE of -0.71%. Regarding short-term risk, TRXB is less volatile compared to HELP. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check HELP's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, SVA has a market cap of 464.9M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while SVA trades at $6.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas SVA's P/E ratio is -5.68. In terms of profitability, TRXB's ROE is N/A, compared to SVA's ROE of -0.01%. Regarding short-term risk, TRXB is more volatile compared to SVA. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check SVA's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, CUVL has a market cap of 249.9M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while CUVL trades at $4.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas CUVL's P/E ratio is 10.68. In terms of profitability, TRXB's ROE is N/A, compared to CUVL's ROE of N/A. Regarding short-term risk, TRXB is more volatile compared to CUVL. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check CUVL's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, HITI has a market cap of 230.9M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while HITI trades at $2.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas HITI's P/E ratio is -9.57. In terms of profitability, TRXB's ROE is N/A, compared to HITI's ROE of -0.36%. Regarding short-term risk, TRXB is more volatile compared to HITI. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check HITI's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, CELG-RI has a market cap of 194.1M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while CELG-RI trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, TRXB's ROE is N/A, compared to CELG-RI's ROE of +0.44%. Regarding short-term risk, TRXB is more volatile compared to CELG-RI. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check CELG-RI's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, ETRA has a market cap of 155.1M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while ETRA trades at $7.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas ETRA's P/E ratio is -2.76. In terms of profitability, TRXB's ROE is N/A, compared to ETRA's ROE of N/A. Regarding short-term risk, TRXB is less volatile compared to ETRA. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check ETRA's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, ATLN has a market cap of 68.6M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while ATLN trades at $0.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas ATLN's P/E ratio is -0.68. In terms of profitability, TRXB's ROE is N/A, compared to ATLN's ROE of -83.20%. Regarding short-term risk, TRXB is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check ATLN's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, CTOR has a market cap of 55.2M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while CTOR trades at $0.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas CTOR's P/E ratio is -1.26. In terms of profitability, TRXB's ROE is N/A, compared to CTOR's ROE of -1.03%. Regarding short-term risk, TRXB is less volatile compared to CTOR. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check CTOR's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, RTSN has a market cap of 43.6M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while RTSN trades at $11.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas RTSN's P/E ratio is -4.45. In terms of profitability, TRXB's ROE is N/A, compared to RTSN's ROE of N/A. Regarding short-term risk, TRXB is less volatile compared to RTSN. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check RTSN's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while RAD trades at $0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas RAD's P/E ratio is -0.05. In terms of profitability, TRXB's ROE is N/A, compared to RAD's ROE of +2.76%. Regarding short-term risk, TRXB is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check RAD's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while GLTO trades at $21.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas GLTO's P/E ratio is -1.78. In terms of profitability, TRXB's ROE is N/A, compared to GLTO's ROE of -0.83%. Regarding short-term risk, TRXB is less volatile compared to GLTO. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check GLTO's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, COSM has a market cap of 31.1M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while COSM trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas COSM's P/E ratio is -0.42. In terms of profitability, TRXB's ROE is N/A, compared to COSM's ROE of -1.19%. Regarding short-term risk, TRXB is less volatile compared to COSM. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check COSM's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, NSRX has a market cap of 27.6M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while NSRX trades at $3.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas NSRX's P/E ratio is -4.44. In terms of profitability, TRXB's ROE is N/A, compared to NSRX's ROE of -1.59%. Regarding short-term risk, TRXB is less volatile compared to NSRX. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check NSRX's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, SCYX has a market cap of 24M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while SCYX trades at $3.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas SCYX's P/E ratio is -1.11. In terms of profitability, TRXB's ROE is N/A, compared to SCYX's ROE of -0.21%. Regarding short-term risk, TRXB is more volatile compared to SCYX. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check SCYX's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, POM has a market cap of 16.4M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while POM trades at $1.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas POM's P/E ratio is -0.28. In terms of profitability, TRXB's ROE is N/A, compared to POM's ROE of +0.80%. Regarding short-term risk, TRXB is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check POM's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, BFRI has a market cap of 13M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while BFRI trades at $0.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas BFRI's P/E ratio is -1.59. In terms of profitability, TRXB's ROE is N/A, compared to BFRI's ROE of -1.28%. Regarding short-term risk, TRXB is less volatile compared to BFRI. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check BFRI's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, CNSY has a market cap of 12.9M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while CNSY trades at $1.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas CNSY's P/E ratio is -0.41. In terms of profitability, TRXB's ROE is N/A, compared to CNSY's ROE of -3.94%. Regarding short-term risk, TRXB is less volatile compared to CNSY. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check CNSY's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, AZR has a market cap of 10.4M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while AZR trades at $3.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas AZR's P/E ratio is -0.24. In terms of profitability, TRXB's ROE is N/A, compared to AZR's ROE of N/A. Regarding short-term risk, TRXB is less volatile compared to AZR. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check AZR's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while CJJD trades at $1.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas CJJD's P/E ratio is -0.46. In terms of profitability, TRXB's ROE is N/A, compared to CJJD's ROE of -0.25%. Regarding short-term risk, TRXB is more volatile compared to CJJD. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check CJJD's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while SSY trades at $1.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas SSY's P/E ratio is -2.86. In terms of profitability, TRXB's ROE is N/A, compared to SSY's ROE of -0.09%. Regarding short-term risk, TRXB is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check SSY's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, SCNX has a market cap of 5.3M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while SCNX trades at $3.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas SCNX's P/E ratio is -1.54. In terms of profitability, TRXB's ROE is N/A, compared to SCNX's ROE of -0.54%. Regarding short-term risk, TRXB is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check SCNX's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, BGMS has a market cap of 5M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while BGMS trades at $0.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas BGMS's P/E ratio is -0.25. In terms of profitability, TRXB's ROE is N/A, compared to BGMS's ROE of -0.32%. Regarding short-term risk, TRXB is more volatile compared to BGMS. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check BGMS's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while MDVL trades at $1.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas MDVL's P/E ratio is -0.05. In terms of profitability, TRXB's ROE is N/A, compared to MDVL's ROE of -2.39%. Regarding short-term risk, TRXB is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check MDVL's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, EOCN has a market cap of 2.8M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while EOCN trades at $2.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas EOCN's P/E ratio is -0.19. In terms of profitability, TRXB's ROE is N/A, compared to EOCN's ROE of N/A. Regarding short-term risk, TRXB is less volatile compared to EOCN. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check EOCN's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, PAVS has a market cap of 2.7M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while PAVS trades at $3.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas PAVS's P/E ratio is -0.03. In terms of profitability, TRXB's ROE is N/A, compared to PAVS's ROE of -0.46%. Regarding short-term risk, TRXB is less volatile compared to PAVS. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check PAVS's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while ATNFW trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas ATNFW's P/E ratio is N/A. In terms of profitability, TRXB's ROE is N/A, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, TRXB is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check ATNFW's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while BGMSP trades at $1.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, TRXB's ROE is N/A, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, TRXB is more volatile compared to BGMSP. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check BGMSP's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while AZNH trades at $53.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas AZNH's P/E ratio is 38.35. In terms of profitability, TRXB's ROE is N/A, compared to AZNH's ROE of +0.00%. Regarding short-term risk, TRXB is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check AZNH's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, ASBP has a market cap of 842.2K. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while ASBP trades at $7.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas ASBP's P/E ratio is -0.31. In terms of profitability, TRXB's ROE is N/A, compared to ASBP's ROE of +19.93%. Regarding short-term risk, TRXB is less volatile compared to ASBP. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check ASBP's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, BFRIW has a market cap of 796.7K. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while BFRIW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas BFRIW's P/E ratio is N/A. In terms of profitability, TRXB's ROE is N/A, compared to BFRIW's ROE of -1.28%. Regarding short-term risk, TRXB is more volatile compared to BFRIW. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check BFRIW's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while LFLYW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, TRXB's ROE is N/A, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, TRXB is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check LFLYW's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, ASBPW has a market cap of 149.5K. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while ASBPW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas ASBPW's P/E ratio is N/A. In terms of profitability, TRXB's ROE is N/A, compared to ASBPW's ROE of +19.93%. Regarding short-term risk, TRXB is less volatile compared to ASBPW. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check ASBPW's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, PRPH has a market cap of 91.1K. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while PRPH trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas PRPH's P/E ratio is N/A. In terms of profitability, TRXB's ROE is N/A, compared to PRPH's ROE of -13.59%. Regarding short-term risk, TRXB is less volatile compared to PRPH. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check PRPH's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, POZN has a market cap of 0. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while POZN trades at $5.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas POZN's P/E ratio is N/A. In terms of profitability, TRXB's ROE is N/A, compared to POZN's ROE of +0.61%. Regarding short-term risk, TRXB is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check POZN's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, CPD has a market cap of 0. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while CPD trades at $5.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas CPD's P/E ratio is N/A. In terms of profitability, TRXB's ROE is N/A, compared to CPD's ROE of N/A. Regarding short-term risk, TRXB is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check CPD's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while SHPG trades at $179.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas SHPG's P/E ratio is 11.35. In terms of profitability, TRXB's ROE is N/A, compared to SHPG's ROE of +0.13%. Regarding short-term risk, TRXB is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check SHPG's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while ESRX trades at $92.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas ESRX's P/E ratio is 10.69. In terms of profitability, TRXB's ROE is N/A, compared to ESRX's ROE of +0.26%. Regarding short-term risk, TRXB is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check ESRX's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while IPXL trades at $18.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas IPXL's P/E ratio is -10.11. In terms of profitability, TRXB's ROE is N/A, compared to IPXL's ROE of -1.16%. Regarding short-term risk, TRXB is less volatile compared to IPXL. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check IPXL's competition here

TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRXB stands at 114.4M. In comparison, OREX has a market cap of 0. Regarding current trading prices, TRXB is priced at $13.64 on the NASDAQ, while OREX trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRXB currently has a P/E ratio of -5.56, whereas OREX's P/E ratio is -0.14. In terms of profitability, TRXB's ROE is N/A, compared to OREX's ROE of -0.54%. Regarding short-term risk, TRXB is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check OREX's competition here